266 related articles for article (PubMed ID: 17419698)
1. Interstitial laser coagulation in the management of lower urinary tract symptoms suggestive of bladder outlet obstruction from benign prostatic hyperplasia: long-term follow-up.
Daehlin L; Frugård J
BJU Int; 2007 Jul; 100(1):89-93. PubMed ID: 17419698
[TBL] [Abstract][Full Text] [Related]
2. Interstitial laser coagulation for management of benign prostatic hyperplasia: long-term follow-up.
Terada N; Arai Y; Okubo K; Ichioka K; Matsui Y; Yoshimura K; Terai A
Int J Urol; 2004 Nov; 11(11):978-82. PubMed ID: 15509201
[TBL] [Abstract][Full Text] [Related]
3. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A
BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441
[TBL] [Abstract][Full Text] [Related]
4. [Interstitial laser coagulation in the treatment of benign prostatic hyperplasia. Preliminary results].
Daehlin L; Mohn J; Høisaeter PA; Hedlund H; Kapstad L; Moen G; Fossberg E
Tidsskr Nor Laegeforen; 1997 Oct; 117(26):3790-3. PubMed ID: 9417682
[TBL] [Abstract][Full Text] [Related]
5. Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement--a prospective randomized study.
Liedberg F; Adell L; Hagberg G; Palmqvist IB
Scand J Urol Nephrol; 2003; 37(6):494-7. PubMed ID: 14675923
[TBL] [Abstract][Full Text] [Related]
6. [Long-term follow-up of interstitial laser coagulation in the treatment of benign prostatic hyperplasia].
Knoll T; Michel MS; Trojan L; Bross S; Alken P; Köhrmann KU
Aktuelle Urol; 2003 Jan; 34(1):48-51. PubMed ID: 14566701
[TBL] [Abstract][Full Text] [Related]
7. The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery.
Masumori N; Furuya R; Tanaka Y; Furuya S; Ogura H; Tsukamoto T
BJU Int; 2010 May; 105(10):1429-33. PubMed ID: 19863522
[TBL] [Abstract][Full Text] [Related]
8. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
[TBL] [Abstract][Full Text] [Related]
9. [Interstitial laser-induced coagulation of the prostate for therapy of benign hyperplasia].
Muschter R; Zellner M; Hessel S; Hofstetter A
Urologe A; 1995 Mar; 34(2):90-7. PubMed ID: 7538715
[TBL] [Abstract][Full Text] [Related]
10. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
[TBL] [Abstract][Full Text] [Related]
11. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction.
Thomas AW; Cannon A; Bartlett E; Ellis-Jones J; Abrams P
J Urol; 2005 Nov; 174(5):1887-91. PubMed ID: 16217330
[TBL] [Abstract][Full Text] [Related]
12. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
[TBL] [Abstract][Full Text] [Related]
13. Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
Hamann MF; Naumann CM; Seif C; van der Horst C; Jünemann KP; Braun PM
Eur Urol; 2008 Oct; 54(4):902-7. PubMed ID: 18502565
[TBL] [Abstract][Full Text] [Related]
14. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Chin PT; Bolton DM; Jack G; Rashid P; Thavaseelan J; Yu RJ; Roehrborn CG; Woo HH
Urology; 2012 Jan; 79(1):5-11. PubMed ID: 22202539
[TBL] [Abstract][Full Text] [Related]
15. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate.
Paick JS; Um JM; Kwak C; Kim SW; Ku JH
Urology; 2007 May; 69(5):859-63. PubMed ID: 17482922
[TBL] [Abstract][Full Text] [Related]
16. Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy.
Kollmorgen TA; Malek RS; Barrett DM
Urology; 1996 Aug; 48(2):217-22. PubMed ID: 8753732
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
18. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
[TBL] [Abstract][Full Text] [Related]
19. Laser prostatectomy: initial experience and urodynamic follow-up.
Cummings JM; Parra RO; Boullier JA
Urology; 1995 Mar; 45(3):414-8; discussion 418-20. PubMed ID: 7533453
[TBL] [Abstract][Full Text] [Related]
20. Interstitial laser coagulation for the treatment of benign prostatic hyperplasia: a 3 year-follow-up of 30 cases.
Kochakarn W; Nilsakulwat S; Roongruangsilp U; Muangman V
J Med Assoc Thai; 2001 Aug; 84(8):1126-30. PubMed ID: 11758847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
